WEWINBRD: Production and validation of host defense peptides-based drugs for the treatment of Bovine Respiratory Disease
Show side menu
Data d'inici:
01/06/2020
Data de fi:
31/05/2023
Programa responsable:
Ruminant Production
Investigador principal:
Entitats finançadores:
WEWINBRD emerges from an effort to develop an effective broad spectrum treatment to control the BRD causing agents, using new proteinaceous drugs based on host defense peptides (HDPs), which have previously shown bactericidal activities against virus, bacteria and fungi.
